NCT06243627

A Study to Assess Safety and Improvement in Skin Barrier After Using 2 Facial Sunscreens in Adults With Sensitive Skin

A Single-Center, Comparative, Randomized, Safety-in-Use Clinical Study to Assess Skin Acceptability and Efficacy in Improving Skin Barrier Function of Two Facial Sunscreens in Adult Participants With Sensitive Skin

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 35 (actual)
• Sponsor: Johnson & Johnson Consumer Inc. (J&JCI) · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this trial is to evaluate 1) the dermatological tolerability of 2 facial sunscreens after 21 (+2) days of use under normal conditions on the half face by adult subjects with sensitive skin, 2) Compare the efficacy of investigational products (IPs) after 21 (+2) days of use in adult subjects with sensitive skin, under dermatological supervision through the following evaluations: the transepidermal water loss in the nasolabial region; the sensory perception of the subjects using the sensory perception questionnaire, after 21 (+2) days of use under normal conditions; the sensitivity of the subjects' skin after the first application of each product using a questionnaire on the perception of signs of discomfort.

Conditions

• Healthy

Interventions

Type	Name	Description
OTHER	Sunscreen C Color 2.0 SPF 70	Sunscreen C color 2.0 SPF 70 will be applied topically on half of the face.
OTHER	Sunscreen C Color 3.0 SPF 70	Sunscreen C color 3.0 SPF 70 will be applied topically on half of the face.
OTHER	Sunscreen M Very Light SPF 50	Sunscreen M very light SPF 50 will be applied topically on half of the face.
OTHER	Sunscreen M Golden Color SPF 50	Sunscreen M golden color SPF 50 will be applied topically on half of the face.

Timeline

• Start date: 2023-09-27
• Primary completion: 2023-11-30
• Completion: 2023-12-11
• First posted: 2024-02-06
• Last updated: 2024-02-06

Locations

1 site across 1 country: Brazil